Kim Smith-Whitley SEC EDGAR Filings (CIK 0001860297)

SEC EDGAR filings, ownership reports, and insider transactions for Kim Smith-Whitley.

Business address
C/O Global Blood Therapeutics, Inc., 181 Oyster Point Blvd., South San Francisco, CA, 94080
Get insider transactions for this reporting owner
Kim Smith-Whitley has filed 7 SEC EDGAR filings since 07 May 2021

Latest Filings

Recent SEC filings for Kim Smith-Whitley including 4, 4/A, 3.

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 06 Oct 2022 05 Oct 2022 001-37539
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 06 Sep 2022 01 Sep 2022 001-37539
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 03 Jun 2022 01 Jun 2022 001-37539
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 03 Mar 2022 01 Mar 2022 001-37539
4/A Open 4/A document View SEC filing for 4/A FORM 4/A SUBMISSION 21 Jun 2021 01 Jun 2021 001-37539
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 02 Jun 2021 01 Jun 2021 001-37539
3 Open 3 document View SEC filing for 3 FORM 3 SUBMISSION 07 May 2021 03 May 2021 001-37539

About this filer

Kim Smith-Whitley files with the SEC under CIK 0001860297. This page aggregates EDGAR filings and related ownership activity.

See reporting owner transactions.

FAQ

What is a CIK?
A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?
New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?
Updates follow new EDGAR submissions and periodic data refreshes.

Related pages